MYELOTEC MYELOSCOPE

K960194 · Myelotec, Inc. · HRX · Sep 4, 1996 · Orthopedic

Device Facts

Record IDK960194
Device NameMYELOTEC MYELOSCOPE
ApplicantMyelotec, Inc.
Product CodeHRX · Orthopedic
Decision DateSep 4, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.1100
Device ClassClass 2

Intended Use

The Myeloscope is intended to be used by physicians for the illumination and visualization of tissues of the epidural space in the lumbar and sacral spine for the purpose of assisting in the diagnosis of disease.

Device Story

Myeloscope is a flexible fiberoptic endoscope system used for micro-endoscopic visualization of the epidural space in the lumbar and sacral spine. System consists of a reusable fiberoptic scope and a sterile, disposable video-guided catheter. Catheter allows steering of the scope tip (30 degrees left/right). Device is operated by physicians in a clinical setting. Input is visual light/image data from the epidural space; output is a visual image for physician observation. Device assists in clinical diagnosis of spinal disease. Benefits include direct visualization of epidural tissues.

Clinical Evidence

Bench testing only. Testing included optical performance, mechanical durability (250-cycle flexion test), sterilization assurance, re-use validation, and biocompatibility of patient-contacting materials.

Technological Characteristics

Flexible fiberoptic endoscope system. Components: reusable fiberoptic scope, sterile disposable video-guided catheter. Steering mechanism allows 30-degree deflection. Materials: biocompatible. Sterilization: validated for re-use. Connectivity: none (standalone optical/video system).

Indications for Use

Indicated for physicians to illuminate and visualize tissues of the epidural space in the lumbar and sacral spine to assist in disease diagnosis.

Regulatory Classification

Identification

An arthroscope is an electrically powered endoscope intended to make visible the interior of a joint. The arthroscope and accessories also is intended to perform surgery within a joint.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 SEP - 4 1996 Myelotec, Inc. c/o Ms. Carolann Kotula Official Correspondent MDI Consultants, Inc. 55 Northern Boulevard, Suite 410 Great Neck, New York 11021 Re: K960194 Trade Name: Myeloscope Regulatory Class: II Product Code: HRX Dated: July 12, 1996 Received: July 16, 1996 Dear Ms. Kotula: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {1} Page 2 - Ms. Carolann Kotula This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597. Sincerely yours, ![img-0.jpeg](img-0.jpeg) Enclosure {2} 510(k) Number (if known): K960194 Device Name: Myeloscope Indications For Use: The Myeloscope is intended to be used by physicians for the illumination and visualization of tissues of the epidural space in the lumbar and sacral spine for the purpose of assisting in the diagnosis of disease. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) ![img-1.jpeg](img-1.jpeg) (Division Sign-Of) Division of General Restorative Devices 510(k) Number Prescription Use ☑ (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) 2 {3} mdi K960194 ATTACHMENT 1 Page 1 of 2 # 510(K) SUMMARY ## MYELOTEC MYELOSCOPE SYSTEM ### Submitter Information: Edward J. Lortie President Myelotec, Inc. 1005 Alderman Drive, Suite 101 Alpharetta, GA 30202 Telephone # (770)-664-4656 510(K) Summary Prepared: June 28, 1996 ### Name of the Device: Trade or Proprietary Name: Myelotec Myeloscope Common Name: Flexible fiberoptic scope with guiding catheter Classification Name: Arthroscope and Accessories (21 CFR Part 888.1100) ### Identification of Legally Marketed Devices To Which The Submitter Claims Equivalence: The Myelotec, Inc. Myeloscope is similar in design and/or intended use to several legally marketed flexible fiberscope endoscopes. These include the Danek Spinal Epidural Endoscope Systems (K930191) and the Ultra-Vu Endoscope Systems (K913129). These are flexible fiberoptic systems used for "micro-endoscopic" applications in small body cavities and spaces. ### Description of the Subject Device: The Myelotec Myeloscope is a flexible fiberoptic system that includes a video guided catheter that allows steering of the fiberoptic scope. The fiberoptic scope is a reusable device that is supplied non-sterile with instructions for cleaning, sterilization and re-use. The video guided catheter is a sterile, disposable device. The optical performance characteristics of the Myelotec Myeloscope are similar to the predicate devices. Consulting since 1978 {4} m d i ATTACHMENT 1 Page 2 of 2 Performance testing of the video guided catheter shows that the catheter is capable of flexing the Myeloscope optics 30 degrees to the right and left for 250 cycle without damage to the tip bonds or steering mechanism. Safety testing included biocompatibility for patient contacting materials. ## Intended Use of the Subject Device The Myeloscope is intended to be used by physicians for the illumination and visualization of tissues of the epidural space in the lumbar and sacral spine for the purpose of assisting in the diagnosis of disease. ## Technological Characteristics of the Subject Device: There are no significant technological characteristics between the Myelotec Myeloscope and the predicate devices. Optical and mechanical performance and materials are similar. Non-clinical testing on the Myelotec Myeloscope included optical, mechanical, sterilization assurance and re-use validations. Consulting since 1978
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%